SFA Therapeutics, Inc

A Major Advancement in Treating Chronic Inflammatory Diseases and Cancer

  • Stage Product In Development
  • Industry Biotechnology
  • Location Jenkintown, PA, US
  • Currency USD
  • Founded December 2016
  • Employees 5
  • Incorporation Type C-corp
  • Website sfatherapeutics.com

Company Summary

SFA is a clinical-stage biotech with a novel platform for chronic inflammatory diseases. Over 125M people suffer from autoimmune diseases. We have 6 oral drugs targeting autoimmune diseases and cancer. We have an IND, Orphan Drug Designation (liver cancer), are in Phase 1b (psoriasis), and are raising funds for Phase 2. We will license these drugs for >$500M. We have >200 yrs of experience, 40 drugs and 8 exits. Our vision is to change Medicine.


  • Founder and CEO

    Experienced drug developer, with over 25 years of R&D experience, involvement in 33 approved NDAs and 12 medical devices.

  • World-class hepatitis expert

  • GI microbiome expert

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free